This week’s episode of “WisBusiness: The Podcast” features Tobias Zutz, founder and CEO of Madison-based Gregor Diagnostics.
He’s developing a method to test seminal fluid for signs of prostate cancer. Zutz is a former employee of Exact Sciences in Madison, which has a similar test for colorectal cancer which relies on stool samples.
“My background has always been R&D,” Zutz said. “I’ve been a bench-level scientist and worked there, so transitioning to more of a business-focused role, putting together a business plan, pitching to investors and getting money — that was all brand new to me.”
The startup has a license agreement with the Wisconsin Alumni Research Foundation, and completed a $900,000 funding round earlier this summer. Gregor Diagnostics recently moved from the 100state coworking space into the pilot space for Forward BIOLABS, and hired several employees. Read the full story here.